Insiders / Clark Ian T
Clark Ian T
CIK 1336504personinsider
Companies
6
First seen
Mar 18, 2026
Last activity
Jun 23, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| Kyverna Therapeutics, Inc. · KYTX | 21,727 | — |
| BioMarin Pharmaceutical Inc · BMRN | 14,490 | — |
| Guardant Health, Inc. · GH | 8,067 | — |
| Corvus Pharmaceuticals, Inc. · CRVS | — | — |
| Olema Pharmaceuticals, Inc. · OLMA | — | — |
| Takeda Pharmaceutical Co Ltd · TAK | — | — |
All securities held
7 positions · latest reported per filing
| Company | Security | Shares |
|---|---|---|
| BioMarin Pharmaceutical Inc | Common Stock | 14,490 |
| Corvus Pharmaceuticals, Inc. | Stock Option (Right to Buy)Derivative | 15,000 |
| Guardant Health, Inc. | Common Stock | 8,067 |
| Guardant Health, Inc. | Restricted Stock UnitsDerivative | 2,711 |
| Kyverna Therapeutics, Inc. | Common Stock | 21,727 |
| Kyverna Therapeutics, Inc. | Stock Option (right to buy)Derivative | 20,582 |
| Olema Pharmaceuticals, Inc. | Stock Option (right to buy)Derivative | 29,500 |
Activity
InsidersInstitutions
This person's insider trades (Form 4), across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| May 20, 2026 | Sell | GH Guardant Health, Inc. Common Stock | $735.0K | -7K -69.80% | 2,975 <0.01% of shares | medium |
| Jun 17, 2026 | Exercise | GH Guardant Health, Inc. Common Stock | $0 | +5K +171.16% | 8,067 <0.01% of shares | low |
| May 27, 2026 | Grant | KYTX Kyverna Therapeutics, Inc. Common Stock | $0 | +5K +30.62% | 21,727 0.04% of shares | low |
| Jun 2, 2026 | Grant | BMRN BioMarin Pharmaceutical Inc Common Stock | $0 | +7K +107.00% | 14,490 <0.01% of shares | low |
| Jun 18, 2026 | Grant | OLMA Olema Pharmaceuticals, Inc. Stock Option (right to buy) | — | +30K | 29,500 0.03% of shares | low |
| Jun 17, 2026 | Grant | GH Guardant Health, Inc. Restricted Stock Units | — | +3K | 2,711 <0.01% of shares | low |
| Jun 17, 2026 | Exercise | GH Guardant Health, Inc. Restricted Stock Units | — | -5K -100.00% | 0 0.00% of shares | low |
| Jun 11, 2026 | Grant | CRVS Corvus Pharmaceuticals, Inc. Stock Option (Right to Buy) | — | +15K | 15,000 0.02% of shares | low |
| May 27, 2026 | Grant | KYTX Kyverna Therapeutics, Inc. Stock Option (right to buy) | — | +21K | 20,582 0.03% of shares | low |